Sharon Ruddock

Randomized Controlled Trial of Rituximab and Cost‐Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome

Simon Bowman, Colin Everett, John O’Dwyer et al. · Arthritis & Rheumatology · 2017 · 264 citations · Full text

Medicine, Immunology, Pharmacotherapy +14

Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer

Peter S Hall, Daniel Swinson, David A. Cairns et al. · JAMA Oncology · 2021 · 191 citations · Full text

Medicine, Geriatric Medicine, Oncology +14

Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy

Benjamin A. Fisher, Colin Everett, John Rout et al. · Annals of the Rheumatic Diseases · 2017 · 107 citations · Full text

Medicine, Diagnostic Sciences, Rheumatology +15

Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial

Gary A. Ford, Bipin Bhakta, Alastair Cozens et al. · The Lancet Neurology · 2019 · 72 citations · Full text

Medicine, Neurology, Rehabilitation Medicine +17

Optimizing chemotherapy for frail and elderly patients (pts) with advanced gastroesophageal cancer (aGOAC): The GO2 phase III trial.

Peter S Hall, Daniel Swinson, Justin S. Waters et al. · Journal of Clinical Oncology · 2019 · 60 citations · Full text

Medicine, Oncology, Pharmacotherapy +17